268 related articles for article (PubMed ID: 19148799)
1. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
Koike K
J Gastroenterol; 2009; 44 Suppl 19():82-8. PubMed ID: 19148799
[TBL] [Abstract][Full Text] [Related]
2. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T
Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115
[TBL] [Abstract][Full Text] [Related]
4. [Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis].
Tanaka N; Aoyama T
Nihon Rinsho; 2004 Nov; 62(11):2137-44. PubMed ID: 15552900
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
7. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
8. Animal models for hepatitis C and related liver disease.
Koike K; Moriya K; Matsuura Y
Hepatol Res; 2010 Jan; 40(1):69-82. PubMed ID: 20156300
[TBL] [Abstract][Full Text] [Related]
9. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.
Moriishi K; Mochizuki R; Moriya K; Miyamoto H; Mori Y; Abe T; Murata S; Tanaka K; Miyamura T; Suzuki T; Koike K; Matsuura Y
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1661-6. PubMed ID: 17234812
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
Koike K
Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and significance of liver steatosis in hepatitis C virus infection.
Negro F
World J Gastroenterol; 2006 Nov; 12(42):6756-65. PubMed ID: 17106922
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
[TBL] [Abstract][Full Text] [Related]
13. Impact of HCV genetic differences on pathobiology of disease.
Ripoli M; Pazienza V
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):747-59. PubMed ID: 21905784
[TBL] [Abstract][Full Text] [Related]
14. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice.
Kato T; Miyamoto M; Date T; Yasui K; Taya C; Yonekawa H; Ohue C; Yagi S; Seki E; Hirano T; Fujimoto J; Shirai T; Wakita T
Cancer Sci; 2003 Aug; 94(8):679-85. PubMed ID: 12901792
[TBL] [Abstract][Full Text] [Related]
15. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
17. Animal models in the study of hepatitis C virus-associated liver pathologies.
Lerat H; Higgs M; Pawlotsky JM
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):341-52. PubMed ID: 21651352
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.
Basaranoglu M; Basaranoglu G
World J Gastroenterol; 2011 Sep; 17(36):4055-62. PubMed ID: 22039318
[TBL] [Abstract][Full Text] [Related]
19. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
Patra T; Sasaki R; Meyer K; Ray RB; Ray R
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
[TBL] [Abstract][Full Text] [Related]
20. [HCV core gene transgenic mouse as a model for viral hepatocarcinogenesis].
Koike K
Nihon Rinsho; 2001 Jul; 59(7):1265-70. PubMed ID: 11494535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
